Emergent Biosolutions reported $84.8M in Selling and Administration Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US $ 96.68M 9.23M
Akebia Therapeutics AKBA:US $ 44.33M 498K
Alnylam Pharmaceuticals ALNY:US $ 154.47M 31.91M
Amarin AMRN:US 90.65M 1.72M
Ani Pharmaceuticals ANIP:US $ 28.82M 1.89M
Biomarin Pharmaceutical BMRN:US $ 194.62M 22.94M
Chimerix CMRX:US 5.63M 391K
Coherus Biosciences CHRS:US $ 48.75M 1.3M
Emergent Biosolutions EBS:US $ 84.8M 9.4M
Exact Sciences EXAS:US $ 401.95M 61.72M
Exelixis EXEL:US $ 102.86M 3.55M
Glaxosmithkline GSK:US 2.68B 227M
Heron Therapeutics HRTX:US $ 32.96M 1.42M
Immunogen IMGN:US $ 16.65M 3.07M
Intercept Pharmaceuticals ICPT:US $ 50.01M 10.58M
Ironwood Pharmaceuticals IRWD:US $ 28.86M 175K
JAZZ PHA JAZZ:US 308.81M 53.95M
Lexicon Pharmaceuticals LXRX:US 8.49M 355K
Merk MRK:US $ 2.3B 518M
Moderna Inc MRNA:US 268M 67M
Myriad Genetics MYGN:US $ 110.6M 33.3M
Nektar Therapeutics NKTR:US $ 27.34M 4.8M
Opko Health OPK:US $ 117.54M 20.68M
Pacira Pharmaceuticals PCRX:US $ 64.26M 13.06M
Ptc Therapeutics PTCT:US $ 73.27M 13.28M
Sarepta Therapeutics SRPT:US $ 71.84M 6.22M
Seattle Genetics SGEN:US $ 174.22M 36.71M
Teva Pharmaceutical Industries TEVA:US 819M 39M
United Therapeutics UTHR:US $ 79M 47.9M
Vanda Pharmaceuticals VNDA:US $ 40.85M 7.4M
Xoma XOMA:US $ 5.12M 422K